Taking note of its benefits, a bench of justices S Ravindra Bhat and AK Chawla quashed the government’s April 27 notification imposing the ban, saying it was "arbitrary and unreasonable".
HC junks ban on sale of Oxytocin by private cos
More from Industry NewsMore posts in Industry News »
- India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference
- India initiates antidumping probe on certain type of steel from Brazil, China, Germany
- BDR Pharma receives DGCI nod for its generic drug BIAPENEM
- AstraZeneca invests in Imperial’s self-amplifying RNA technology with eye on future drugs